This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

reputable news agency

proofread

After criticism, FDA pledges to revamp its tobacco division

After criticism, FDA pledges to revamp its tobacco division

The U.S. Food and Drug Administration's heavily criticized tobacco program promised changes on Friday, including a five-year strategic plan to better outline priorities.

"As we enter this era of declining use of combustible tobacco and continued innovation in the e-cigarette industry, the societal concerns are not subtle," FDA Commissioner Dr. Robert Califf said in an agency news release. "Our ability to keep pace with these changes will depend on immediate, short-term and long-term actions the center is taking that we believe will position the agency to more successfully implement our regulatory oversight of tobacco products."

The agency has faced criticism from anti-tobacco advocates, the industry and lawmakers for its past work in cigarette and vaping regulation, the Associated Press reported.

An external review commissioned last summer released a report in December that called the FDA "reactive and overwhelmed."

Its workforce was struggling to manage tobacco and largely unauthorized e-cigarettes, the report stated.

The FDA's new is expected to outline efforts on e-cigarettes, as well as to be more transparent about FDA decisions, such as mass rejection of applications from e-cigarette makers.

Regulators would like to "better communicate" with companies about how the FDA makes decisions, said Brian King, tobacco chief for the agency.

"Some things will take longer than others, but we're committed to getting everything done that we've outlined as expeditiously as possible," King told the AP.

The FDA will also meet with the U.S. Department of Justice on efforts to crack down on the fruit- and candy-flavored e-cigarettes that appeal to teens, King said.

While want more aggressive regulation, argue that the FDA won't approve new alternatives that may help adults quit smoking, the AP reported.

Hundreds of warning letters to vaping retailers and e-cigarette manufacturers are sometimes ignored, the FDA noted. King said the FDA relies on the Justice Department on when to bring on lawsuits. The two agencies have announced lawsuits and fines in recent months.

"Those are the first of their kind, and I hope they're a wake-up call to industry that if you are violating the law we are going to use the full portfolio of our enforcement activities to ensure that you comply," King told the AP.

"Unfortunately, the has fought the agency on many of the science-based actions we've taken, putting profits over ," King said.

More information: The U.S. Centers for Disease Control and Prevention has more on e-cigarettes.

Copyright © 2023 HealthDay. All rights reserved.

Citation: After criticism, FDA pledges to revamp its tobacco division (2023, February 27) retrieved 3 March 2024 from https://medicalxpress.com/news/2023-02-criticism-fda-pledges-revamp-tobacco.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Panel warns FDA's beleaguered tobacco unit lacks direction

2 shares

Feedback to editors